HCW Biologics Inc.
HCWB
$2.46
-$0.05-1.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -69.61% | 10.95% | -58.23% | 9.89% | 110.02% |
| Total Receivables | -14.35% | -14.51% | -94.47% | -95.29% | -96.70% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -4.40% | 16.19% | -32.30% | -40.85% | -27.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -30.71% | -72.98% | -31.63% | 184.11% | -14.34% |
| Total Current Assets | -60.65% | -9.15% | -59.91% | -24.15% | 21.43% |
|
|
|||||
| Total Current Assets | -60.65% | -9.15% | -59.91% | -24.15% | 21.43% |
| Net Property, Plant & Equipment | -8.35% | -8.77% | -8.86% | -1.45% | -0.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -7.41% | 4.02% | -18.91% | -4.18% | 7.79% |
|
|
|||||
| Total Accounts Payable | -45.18% | -40.28% | -41.15% | -16.31% | 14.68% |
| Total Accrued Expenses | 5.44% | -4.10% | 15.30% | 16.54% | -82.78% |
| Short-term Debt | 2.18% | 5.50% | 7.83% | 7.36% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -63.80% | -- | -- |
| Total Other Current Liabilities | -- | -- | -63.80% | -- | -- |
| Total Current Liabilities | -30.54% | -26.47% | -28.91% | -10.65% | 15.62% |
|
|
|||||
| Total Current Liabilities | -30.54% | -26.47% | -28.91% | -10.65% | 15.62% |
| Long-Term Debt | -- | -- | -- | -- | -96.29% |
| Short-term Debt | 2.18% | 5.50% | 7.83% | 7.36% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -60.39% | -- | -- | -- | -- |
| Total Liabilities | -33.22% | -38.07% | -41.21% | -24.57% | -12.56% |
|
|
|||||
| Common Stock & APIC | 12.48% | 17.64% | 18.65% | 22.83% | 20.29% |
| Retained Earnings | -5.33% | -2.23% | -7.92% | -12.40% | -12.22% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 14,383.85% | 167.30% | 140.84% | 78.86% | 99.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14,383.85% | 167.30% | 140.84% | 78.86% | 99.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14,383.85% | 167.30% | 140.84% | 78.86% | 99.17% |
|
|
|||||